Literature DB >> 10576344

Results of retrograde transhepatic biliary drainage after a common bile duct exploration for choledocholithiasis.

T Kusano1, T Isa, H Shimoji, H Miyazato, Y Muto, M Furukawa.   

Abstract

BACKGROUND/AIMS: The purpose of this study is to assess the benefits of retrograde transhepatic biliary drainage (RTBD) and a primary closure after a common bile duct (CBD) exploration for patients with choledocholithiasis.
METHODOLOGY: We analyzed 143 patients with choledocholithiasis who had been managed by RTBD after undergoing a CBD exploration retrospectively over a 12-year period. The main outcome criteria were frequency of occurrence of post-operative complications which needed a relaparotomy and the clinical long-term results. In addition, the radiographic diameter changes of the CBD at the site of the primary closure and liver function tests after RTBD were also evaluated.
RESULTS: The frequency of bile peritonitis in the patients undergoing the RTBD procedure was only 0.7% (1 out of 143 cases). Cholangiography via the RTBD tube revealed no severe stenosis at the site of primary closure. Liver function returned to normal on day 3 after RTBD (p<0.05). Recurrence of common bile duct stones developed in 2 patients in this series during the follow-up (1-12 years).
CONCLUSIONS: RTBD and a primary closure of the CBD after CBD exploration appears to be a clinically safe and effective method for such patients with choledocholithiasis who had undergone a complete stone removal intra-operatively.

Entities:  

Mesh:

Year:  1999        PMID: 10576344

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Feasibility of biodegradable PLGA common bile duct stents: an in vitro and in vivo study.

Authors:  Xiaoyi Xu; Tongjun Liu; Shaohui Liu; Kai Zhang; Zhen Shen; Yuxin Li; Xiabin Jing
Journal:  J Mater Sci Mater Med       Date:  2009-01-09       Impact factor: 3.896

2.  Management of common bile duct stones: a ten-year experience at a tertiary care center.

Authors:  Sebastiano Lacitignola; Martino Minardi
Journal:  JSLS       Date:  2008 Jan-Mar       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.